Glyscend study reveals metabolic benefits of its oral polymer-based duodenal exclusion therapy
Glyscend has presented data from a study of its proprietary oral polymer duodenal exclusion therapy, at the American Diabetes Association...
top of page
Browse by category
Search
Browse by tag
bottom of page